Gerald L. Ray & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $998K | Hold |
10,725
| – | – | 0.12% | 156 |
|
|
2017
Q2 | $974K | Hold |
10,725
| – | – | 0.13% | 157 |
|
|
2017
Q1 | $941K | Buy |
10,725
+500
| +5% | +$43.9K | 0.13% | 151 |
|
|
2016
Q4 | $847K | Buy |
10,225
+784
| +8% | +$64.9K | 0.12% | 152 |
|
|
2016
Q3 | $873K | Sell |
9,441
-484
| -5% | -$44.8K | 0.13% | 145 |
|
|
2016
Q2 | $772K | Buy |
9,925
+250
| +3% | +$19.4K | 0.12% | 148 |
|
|
2016
Q1 | $798K | Sell |
9,675
-600
| -6% | -$49.5K | 0.13% | 140 |
|
|
2015
Q4 | $1.08M | Hold |
10,275
| – | – | 0.17% | 111 |
|
|
2015
Q3 | $1.08M | Hold |
10,275
| – | – | 0.18% | 109 |
|
|
2015
Q2 | $1.41M | Hold |
10,275
| – | – | 0.21% | 105 |
|
|
2015
Q1 | $1.28M | Hold |
10,275
| – | – | 0.19% | 110 |
|
|
2014
Q4 | $929K | Hold |
10,275
| – | – | 0.14% | 131 |
|
|
2014
Q3 | $742K | Sell |
10,275
-400
| -4% | -$28.9K | 0.12% | 152 |
|
|
2014
Q2 | $664K | Hold |
10,675
| – | – | 0.11% | 163 |
|
|
2014
Q1 | $728K | Sell |
10,675
-100
| -0.9% | -$6.82K | 0.13% | 142 |
|
|
2013
Q4 | $758K | Buy |
10,775
+700
| +7% | +$49.2K | 0.14% | 136 |
|
|
2013
Q3 | $727K | Buy |
10,075
+1,975
| +24% | +$143K | 0.15% | 134 |
|
|
2013
Q2 | $451K | Buy |
+8,100
| New | +$451K | 0.1% | 167 |
|